Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
The ESC Working Group on Cardiovascular Pharmacotherapy has developped an engaging and interactive educational programme to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials. Please find below resources from October 2016 Course and Workshop held in conjunction with EuroThrombosis Meeting, London, UK. This programme is supported with an educational grant by Amgen & Daiichi Sankyo.
Sven Wassmann, MD, PhD, FESC
Giuseppe MC Rosano, MD, PhD, FESC
An overview of the different aspects of clinical trials - Niessner
Traditional versus novel trial designing - G.M.C. Rosano
The objectives, the site, the finance and the role of the ethics committee and research organization - B.S. Lewis
Requirements from regulatory agencies: endpoints, comparators, type of studies - G.M.C. Rosanor
Post marketing surveillance - Walther
The role of the principal investigator: keys to success, perils and tribulations - B.S. Lewis
The team, the procedures, the monitor and the sponsor - B.S. Lewis
Randomised controlled trials - Niessner
Observational trials and registries - G.L. Savarese
Meta-analyses and systematic reviews - G.L. Savarese
GCP for the busy investigator (certificate included) -D. Rolfe
Examples from recent clinical trials - Wassmann, Panelists
Certificates and closing remarks - B.S. Lewis, S. Wassmann
This course was supported with an educational grant by
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.